Subscribe

Publications Update

Publications Update # 104

New Episode of GYOEDU Podcast, ASCO abstracts - Challenge trial, TRUST trial, cytoxan+Avastin vs. cytoxan+Avastin+Pembrolizumab, Menopause management with Elinzatenant, and a review of cancer of unknown primary site.

Publications Update # 103

MIS in cervical cancer in SHAPE trial-eligible patients, pragmatic testing with IHC rather to replace the PROMISE algorithm and two questions about PFT and vulvar cancer groin management.

Publications Update # 102

Happiest country, PDS Vs. NACT a fresh perspective (video), fear in the OR, and a vulvar cancer review article worth reading.

Publications Update # 101

Interview with Isabel Allende, updated tips for staying organized for the board prep, p53 staining in endometrial cancer, secondary debulking in platinum-sensitive ovarian cancer, Epigenetic MLH1 and outcomes

Publications Update # 100

Unreasonable hospitality, mini-tutorial juvenile granulosa cell tumor, when to make a protective stoma in ovarian cancer, NRG-GY023 trial, finding the ureter and RSO surgical technique and a review paper on HGSOC

Publications Update # 99

Managing perfectionism, conization prior to open radical hysterectomy, KELIM score in ovarian cancer with mini-video tutorial

Publications Update # 98

"Have you been there?" an award winning speech, INSPIRE-4 clinical trial discussing intra-abdominal infection treatment, Phase 2 LIGHT study exploring PARPs in ovarian cancer, link to a prior PARP tutorial, consolidation cycles in GTN treatment

Publications Update # 97

Taylor Swift and her business, venous thromboembolism in cancer patients - duration of treatment, dose of pembrolizumab and lenvatinib, metformin in endometrial cancer, and the cost of ADCs

Publications Update # 96

The Paradox of hard work, Trastuzumab Deruxtecan and the management of interstitial lung disease and chemo cards for IFOS/Mesna and Doxorubicin

Publications Update # 95

Ed Yong's NYT Interview, Deep Dive into the role of chemoradiation in intermediate and high-risk cervical cancer post radical hysterectomy (GOG 263 and RTOG/GOG 0724 studies), GY-006 final publication.